Algo version: 0.98b
Tianda Pharmaceuticals is listed at the HKSE Exchange
Tianda Pharmaceuticals [0455.HK]
HKSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Tianda Pharmaceuticals stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Tianda Pharmaceuticals pays dividends. Last time was Friday 28th of June 2024 where the investors holding the stock on Thursday 13th of June 2024 were paid HKD0.0026 per share. Over the last 15 times between 2010 and 2024, Tianda Pharmaceuticals has paid HKD0.0562 with an average of HKD0 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Tianda Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD0.201, you would have made a profit of HKD0.0370 per share or 18.41%

No, the average daily trading liquidity for Tianda Pharmaceuticals is HKD14 354 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Tianda Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Tianda Pharmaceuticals to be high [0.75 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.